[Elsevier] Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial

Pandisan Post time Half hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-19 03:37
Reward10points

Journal: The Lancet

Authors: Sean Wharton, MD[url=]a[/url],[url=]b[/url],[url=]c[/url],[url=]d[/url] Send email to [email protected] ∙ Paula Freitas, PhD[url=]e[/url],[url=]f[/url] ∙ Jøran Hjelmesæth, MD[url=]g[/url],[url=]h[/url] ∙ Maria Kabisch, PhD[url=]i[/url] ∙ Kristian Kandler, MD[url=]i[/url] ∙ Prof Ildiko Lingvay, MD[url=]j[/url] ∙ et al. Show more

Published: November 2025
DOI: https://doi.org/10.1016/s2213-8587(25)00225-6

Article Link: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00226-8/abstract

Remark: Please help me find this paper :)

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
Sweetums33 Post time Half hour(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Intermediate member
  • post

  • reply

  • points

    330

Return to the list